nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A COMPARISON OF WHOLE PAROTID AND PARTIAL PAROTID GLAND SPARING IMRT TECHNIQUES IN HEAD AND NECK CANCERS
|
Miah, A. |
|
2011 |
98 |
S1 |
p. S43- 1 p. |
artikel |
2 |
ACUTE AND LATE RADIATION-INDUCED SWALLOWING DYSFUNCTION IN HEAD AND NECK RADIOTHERAPY
|
Langendij, H. |
|
2011 |
98 |
S1 |
p. S16- 1 p. |
artikel |
3 |
ACUTE TOXICITY AND EFFICACY OF CHEMO-RADIATION USING CARBOPLATIN COMPARED WITH CISPLATIN IN HEAD AND NECK CANCER
|
Wilkins, A. |
|
2011 |
98 |
S1 |
p. S35- 1 p. |
artikel |
4 |
ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK: A SINGLE-CENTER ANALYSIS OF 105 CASES
|
van Weert, S. |
|
2011 |
98 |
S1 |
p. S35-S36 2 p. |
artikel |
5 |
ALPHA-CRADLE WITH FOUR-POINT FIXATION THERMOPLASTIC MASK SYSTEM: AN IMPROVEMENT OF REPOSITIONING ACCURACY IN HEAD AND NECK RADIOTHERAPY
|
Pang, E. |
|
2011 |
98 |
S1 |
p. S36- 1 p. |
artikel |
6 |
A NEW FUNCTION FOR HEAD & NECK ACCELERATED REPOPULATION
|
Herrera, M.A. Carrasco |
|
2011 |
98 |
S1 |
p. S27- 1 p. |
artikel |
7 |
A NOVEL APPROACH TO MODELLING XEROSTOMIA BASED ON THE SHAPE OF THE 3D DOSE-DISTRIBUTION AND CLINICAL FACTORS
|
Buettner, F. |
|
2011 |
98 |
S1 |
p. S35- 1 p. |
artikel |
8 |
A PREDICTIVE MODEL FOR FEEDING TUBE DEPENDENCY AFTER CURATIVE RADIOTHERAPY OR CHEMORADIATION IN HEAD AND NECK CANCER
|
Langendijk, H. |
|
2011 |
98 |
S1 |
p. S14- 1 p. |
artikel |
9 |
ARCON FOR T2-T4 LARYNGEAL CANCER: RESULTS OF A PHASE 111 RANDOMIZED TRIAL
|
Kaanders, J. |
|
2011 |
98 |
S1 |
p. S5- 1 p. |
artikel |
10 |
A RETROSPECTIVE REVIEW OF PATIENTS WITH SCCHN TREATED WITH INDUCTION CHEMOTHERAPY BETWEEN 1999–2008
|
Bontill, T. |
|
2011 |
98 |
S1 |
p. S28- 1 p. |
artikel |
11 |
ASSOCIATION BETWEEN GENETIC POLYMORPHISMS IN THE XRCC1, XRCC3, RAD51 AND GSTP1 GENES AND CLINICAL RADIOSENSITIVITY IN HEAD AND NECK CANCER PATIENTS
|
Paiar, F. |
|
2011 |
98 |
S1 |
p. S24- 1 p. |
artikel |
12 |
ASSOCIATION BETWEEN THE EGFR-R497K POLYMORPHISM AND OVERALL SURVIVAL IN PATIENTS WITH ADVANCED CANCER OF THE HEAD AND NECK RECEIVING CETUXIMAB BASED TREATMENT
|
Stöhlmacher, J. |
|
2011 |
98 |
S1 |
p. S24- 1 p. |
artikel |
13 |
Author index
|
|
|
2011 |
98 |
S1 |
p. S47-S49 3 p. |
artikel |
14 |
BASALOID SQUAMOUS CELL CARCINOMA IN OUR ENT DEPARTMENT: A RETROSPECTIVE REVIEW OF 24 PATIENTS
|
Escamilla, Y. |
|
2011 |
98 |
S1 |
p. S36- 1 p. |
artikel |
15 |
BENDAMUSTINE AND CETUXIMAB IN COMBINATION AS ALTERNATIVE THERAPEUTIC OPTION FOR RECURRENT HEAD AND NECK CANCER
|
Tschechne, B. |
|
2011 |
98 |
S1 |
p. S26- 1 p. |
artikel |
16 |
CAN FDG CT/PET BE USEFUL AFTER INDUCTION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER?
|
Bacigaiupo, A. |
|
2011 |
98 |
S1 |
p. S44- 1 p. |
artikel |
17 |
CASE CONTROL STUDY FOR THE DETECTION OF HPV IN PATIENTS WITH HEAD AND NECK CANCER
|
Xesfyngi, D. |
|
2011 |
98 |
S1 |
p. S36-S37 2 p. |
artikel |
18 |
CELL CYCLE GENE EXPRESSION ANALYSIS IN HEAD AND NECK CANCER SUGGESTS THE EXISTENCE OF PATIENTS SUBPOPULATIONS WITH DIFFERENT MOLECULAR PROFILES
|
Herok, R. |
|
2011 |
98 |
S1 |
p. S24- 1 p. |
artikel |
19 |
CHANGES IN THE CLINICOPATHOLOGIC CHARACTERISTICS AND DIAGNOSTIC INTERVALS IN H&N SCC ALONG 20 YEARS
|
Aguilà, A.F. |
|
2011 |
98 |
S1 |
p. S28- 1 p. |
artikel |
20 |
CHEMOTHERAPY/TARGETED AGENTS (STATE OF THE ART TODAY)
|
Machiels, J.P. |
|
2011 |
98 |
S1 |
p. S17- 1 p. |
artikel |
21 |
CLINICAL PROSPECTIVE STUDY OF VOLUME AND DOSIMETRIC CHANGES DURING FRACTIONATED RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER
|
Albiac, M. Ramos |
|
2011 |
98 |
S1 |
p. S37- 1 p. |
artikel |
22 |
COMORBIDITY AMONG 13,651 HEAD AND NECK CANCER PATIENTS FROM THE DAHANCA-DATABASE
|
Boeje, C.R. |
|
2011 |
98 |
S1 |
p. S5-S6 2 p. |
artikel |
23 |
CO-MORBIDITY AND TREATMENT OUTCOMES OF ELDERLY PHARYNGEAL CANCER PATIENTS: A CASE-CONTROL STUDY
|
Peters, T. |
|
2011 |
98 |
S1 |
p. S23- 1 p. |
artikel |
24 |
CORRELATION OF HPV STATUS TO PRETREATMENT FUNCTIONAL IMAGING IN PATIENTS WITH OROPHARYNGEAL CANCER
|
Lambrecht, M. |
|
2011 |
98 |
S1 |
p. S44- 1 p. |
artikel |
25 |
CUSTOMIZING THERAPY FOR HPV-NEGATIVE HEAD AND NECK CARCINOMA
|
Ang, K. |
|
2011 |
98 |
S1 |
p. S5- 1 p. |
artikel |
26 |
DIFFERENT APPROACHES TO VOLUME ASSESSMENT OF LYMPH NODES IN CT SCANS OF HNSCC IN COMPARISON WITH A REAL GOLD STANDARD
|
Mueller, S. |
|
2011 |
98 |
S1 |
p. S44-S45 2 p. |
artikel |
27 |
DIFFUSION-WEIGHTED MR IMAGING APPLICATION IN EVALUATION OF RESPONSE TO TREATMENT OF HEAD AND NECK REGION CANCER
|
Jedrzejewska, M. |
|
2011 |
98 |
S1 |
p. S37- 1 p. |
artikel |
28 |
3D-OPTIMISED IMAGE-GUIDED IR-192 HDR BRACHYTHERAPY IN ORAL CANCER MULTIMODAL TREATMENT
|
Titova, V. |
|
2011 |
98 |
S1 |
p. S27- 1 p. |
artikel |
29 |
DOSIMETRIC AND CLINICAL EVALUATION OF BRACHIAL PLEX-OPATHY IN PATIENTS WITH HEAD AND NECK CANCER TREATED WITH INTENSITY MODULATED RADIOTHERAPY
|
Igdem, S. |
|
2011 |
98 |
S1 |
p. S21- 1 p. |
artikel |
30 |
DWI ADC AS A PREDICTIVE FACTOR OF THE RESPONSE TO RADIOCHEMOTHERAPY IN HEAD AND NECK CANCER
|
Hejduk, B. |
|
2011 |
98 |
S1 |
p. S45- 1 p. |
artikel |
31 |
EARLY CLINICAL OUTCOMES OF HELICAL TOMOTHERAPY WITH SIMULTANEOUS INTEGRATED BOOST IN THE CONCURRENT RADIO-CHEMOTHERAPY OF LOCALLY ADVANCED HEAD AND NECK CANCER
|
Usychkin, S. |
|
2011 |
98 |
S1 |
p. S37- 1 p. |
artikel |
32 |
EARLY DECANNULATION BEFORE STARTING SWALLOWING TRAINING IN SCPL
|
Manciocco, V. |
|
2011 |
98 |
S1 |
p. S28- 1 p. |
artikel |
33 |
Editorial Board
|
|
|
2011 |
98 |
S1 |
p. iv- 1 p. |
artikel |
34 |
ENTERAL FEEDING INCREASES THE WELL-BEING FOR PATIENTS WITH HEAD AND NECK CANCER UNDERGOING RADIATION THERAPY AND LOWER THE COST IN OUT-PATIENT CARE
|
Göransson, H. |
|
2011 |
98 |
S1 |
p. S38- 1 p. |
artikel |
35 |
EVALUATION OF SALIVARY GLAND FUNCTION AFTER TREATMENT OF NASOPHARYNGEAL CARCINOMA BY PERTECHNETATE SCINTIGRAPHY
|
Mnejja, W. |
|
2011 |
98 |
S1 |
p. S21- 1 p. |
artikel |
36 |
EVALUATION OF TOXICITY AND EFFECTIVENESS OF SIB-IMRT RADIOTHERAPY GIVEN CONCOMITANTLY WITH CISPLATIN FOR LOCALLY ADVANCED SQUAMOUS CELL HEAD AND NECK CANCER
|
Kiprian, D. |
|
2011 |
98 |
S1 |
p. S28-S29 2 p. |
artikel |
37 |
EVALUATION OF TOXICITY WITH CONCURRENT CETUXIMAB AND RADIOTHERAPY IN HEAD AND NECK CANCER
|
Vigo, R. Carmona |
|
2011 |
98 |
S1 |
p. S21- 1 p. |
artikel |
38 |
EVOLUTION OF THE SURGICAL APPROACH TO ORAL SQUAMOUS CELL CARCINOMA IN A SINGLE INSTITUTION. DECISIVE IMPACT OF THE IMPROVEMENT OF THE RECONSTRUCTIVE TECHNIQUES EVALUATED ON A SERIES OF 106 PATIENTS BETWEEN 2004 AND 2009
|
Bussu, F. |
|
2011 |
98 |
S1 |
p. S29- 1 p. |
artikel |
39 |
EXCELLENT IDENTICAL OUTCOMES FOR RADIATION ALONE VS CHEMORADIATION IN MINIMAL SMOKING HPV (+) NO-N2C OROPHARYNX CANCER PATIENTS
|
O'Sullivan, B. |
|
2011 |
98 |
S1 |
p. S9-S10 2 p. |
artikel |
40 |
EXTENT OF THYROIDECTOMY FOR PAPILLARY THYROID CANCER. WILL THE CONTROVERSY EVER END?
|
Hamoirl, M. |
|
2011 |
98 |
S1 |
p. S7- 1 p. |
artikel |
41 |
FACTORS ASSOCIATED WITH ACUTE AND LATE DYSPHAGIA IN THE DAHANCA 6 & 7 TRIAL
|
Mortensen, H.R. |
|
2011 |
98 |
S1 |
p. S13- 1 p. |
artikel |
42 |
FLEXIBLE CARBON DIOXIDE LASER IN ORAL SURGERY: OUR EXPERIENCE
|
Damiani, V. |
|
2011 |
98 |
S1 |
p. S38- 1 p. |
artikel |
43 |
HADRONTHERAPY FOR SINONASAL MALIGNANCIES AND SKULL BASE TUMORS
|
Hug, E. |
|
2011 |
98 |
S1 |
p. S18- 1 p. |
artikel |
44 |
HEAD AND NECK MUCOSAL MALIGNANT MELANOMA EXPRESSING C-KIT MIGHT BENEFIT FROM NEW TREATMENT OPTION
|
Cederblad, L. |
|
2011 |
98 |
S1 |
p. S24- 1 p. |
artikel |
45 |
HEAD AND NECK SARCOMA, WHAT'S ABOUT TREATMENT?
|
Kerboua, E. |
|
2011 |
98 |
S1 |
p. S38- 1 p. |
artikel |
46 |
HISTOLOGICAL DISTRIBUTION OF CERVICAL NODAL METAS-TASES FROM ORO-PHARYNX CARCINOMA AND SELECTIVE RADIOTHERAPY
|
Rodriguez-Ibarria, N. |
|
2011 |
98 |
S1 |
p. S29- 1 p. |
artikel |
47 |
HOW TO COMBINE RADIATION AND MONOCLONAL ANTIBODY THERAPIES IN HEAD AND NECK CANCER?
|
Pedicini, P. |
|
2011 |
98 |
S1 |
p. S26- 1 p. |
artikel |
48 |
HYPOXIC GENE EXPRESSION WITH PROGNOSTIC AND PREDICTIVE IMPACT FOR HYPOXIC MODIFICATION IN HEAD AND NECK CANCER
|
Toustrup, K. |
|
2011 |
98 |
S1 |
p. S8-S9 2 p. |
artikel |
49 |
IMAGE GUIDED RT FOR H&N CANCER
|
Rasch, C. |
|
2011 |
98 |
S1 |
p. S11- 1 p. |
artikel |
50 |
IMAGE GUIDED TREATMENTS – MOLECULAR IMAGING
|
Fanti, S. |
|
2011 |
98 |
S1 |
p. S12- 1 p. |
artikel |
51 |
IMAGING TUMOUR PERFUSION AND OXIDATIVE METABOLISM ON PATIENTS WITH H&N CANCER USING ACE-PET DURING RADIOTHERAPY
|
Johansson, S. |
|
2011 |
98 |
S1 |
p. S26- 1 p. |
artikel |
52 |
IMPACT OF ANTIBIOTIC PROPHYLAXIS PROTOCOL IN THE DEVELOPMENT OF WOUND INFECTION IN SALVAGE LARYNGECTOMY
|
Scotton, W. |
|
2011 |
98 |
S1 |
p. S29-S30 2 p. |
artikel |
53 |
IMPACT OF RADIATION THERAPY ON LOCOREGIONAL CONTROL IN MERKEL CELL CARCINOMA OF THE HEAD AND NECK
|
Vigo, R. Carmona |
|
2011 |
98 |
S1 |
p. S30- 1 p. |
artikel |
54 |
INDUCTION CHEMOTHERAPY FOLLOWED BY CONCURRENT CETUXIMAB WITH EXTERNAL BEAM RADIOTHERAPY FOR RECURRENT NASOPHARYNGEAL CARCINOMA
|
Chua, T.T.D. |
|
2011 |
98 |
S1 |
p. S27- 1 p. |
artikel |
55 |
INDUCTION CHEMOTHERAPY WITH TPF PRIOR TO SURGERY – A CASE SERIES
|
Paterson, C. |
|
2011 |
98 |
S1 |
p. S38- 1 p. |
artikel |
56 |
INDUCTION DOCETAXEL AND S-1 FOLLOWED BY CONCOMITANT RADIOTHERAPY WITH LOW-DOSE DAILY CISPLATIN IN LOCALLY ADVANCED HEAD AND NECK CARCINOMA
|
Keum, K.C. |
|
2011 |
98 |
S1 |
p. S30- 1 p. |
artikel |
57 |
INTERNATIONAL SURVEY ON HPV BURDEN AND GENOTYPE DISTRIBUTION IN HEAD AND NECK AND ANOGENITAL CANCERS AND CALL FOR COLLABORATION
|
Alemany, L. |
|
2011 |
98 |
S1 |
p. S25- 1 p. |
artikel |
58 |
INVESTIGATING FUNCTIONAL MRI AS A SURROGATE MARKER OF EARLY RESPONSE TO CHEMORADIATION IN HEAD AND NECK CANCER
|
Powell, C. |
|
2011 |
98 |
S1 |
p. S45- 1 p. |
artikel |
59 |
IS P16 IMMUNOHISTOCHEMISTRY A SURROGATE FOR THE PRESENCE OF AN HPV INFECTION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA?
|
Weynand, B. |
|
2011 |
98 |
S1 |
p. S10- 1 p. |
artikel |
60 |
IS PRE-OPERATIVE TRACHEOSTOMY A RISK FACTOR FOR POOR OUTCOME FOLLOWING TOTAL LARYNGECTOMY?
|
Pezier, T. |
|
2011 |
98 |
S1 |
p. S39- 1 p. |
artikel |
61 |
LARYNGEAL CANCER IN TARRAGONA CANCER REGISTRY (TCR) SPAIN. RELATIVE SURVIVAL BY AGE AND STAGE
|
Mur, E. |
|
2011 |
98 |
S1 |
p. S39- 1 p. |
artikel |
62 |
LATE TOXICITIES AFTER CONVENTIONAL RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA: INCIDENCE AND RISK FACTORS
|
Daoud, J. |
|
2011 |
98 |
S1 |
p. S39-S40 2 p. |
artikel |
63 |
LIMITS OF ENDOSCOPIC SURGERY FOR SINONASAL MALIGNANCIES
|
Nicolai, P. |
|
2011 |
98 |
S1 |
p. S17- 1 p. |
artikel |
64 |
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS
|
Bossi, p. |
|
2011 |
98 |
S1 |
p. S9- 1 p. |
artikel |
65 |
LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA: A COMPARISON, BETWEEN HELICAL TOMOTHERAPY AND STEP & SHOOT IMRT, TOWARDS THE NEW CONTOURING BOUNDARIES
|
Vagge, S. |
|
2011 |
98 |
S1 |
p. S40- 1 p. |
artikel |
66 |
LOCALLY ADVANCED OROPHARYNGEAL CANCER IN THE ELDERLY – TREATMENT COMPLIANCE AND OUTCOME
|
Geropantas, K. |
|
2011 |
98 |
S1 |
p. S23- 1 p. |
artikel |
67 |
MEDULLARY THYROID CANCER (MTC): RESULTS OF TAILORED TREATMENT
|
Andry, G. |
|
2011 |
98 |
S1 |
p. S30-S31 2 p. |
artikel |
68 |
MINIMALLY INVASIVE VIDEO-ASSISTED THYROIDECTOMY (MIVAT)
|
Miccolil, P. |
|
2011 |
98 |
S1 |
p. S7- 1 p. |
artikel |
69 |
MODIFICATION OF TNM USING PET-CT FOR RADIOTHERAPY PLANNING IN HEAD AND NECK CANCER
|
Ruiz Alonso, A.M. |
|
2011 |
98 |
S1 |
p. S31- 1 p. |
artikel |
70 |
MORBIDITY AFTER SURGICAL TREATMENT
|
Roger, S. |
|
2011 |
98 |
S1 |
p. S16- 1 p. |
artikel |
71 |
MULTI-CENTER VALIDATION OF A LYMPH NODE METASTASIS GENE-EXPRESSION SIGNATURE FOR HEAD AND NECK SQUAMOUS CELL CARCINOMAS
|
Takes, R. |
|
2011 |
98 |
S1 |
p. S8- 1 p. |
artikel |
72 |
NARROW BAND IMAGING AND HIGH DEFINITION TELEVISION IN DIAGNOSIS AND SURVEILLANCE OF HEAD AND NECK CANCER
|
Piazza, C. |
|
2011 |
98 |
S1 |
p. S8- 1 p. |
artikel |
73 |
NEW THOUGHTS ON TREATMENT RELATED MUCOSITIS IN HEAD AND NECK CANCER PATIENTS
|
Treiste, N. |
|
2011 |
98 |
S1 |
p. S16- 1 p. |
artikel |
74 |
PAPILLARY THYROID CANCER (PTC): IDENTIFICATION OF PRE-CURSOR LESIONS
|
LambaSaini, M. |
|
2011 |
98 |
S1 |
p. S25- 1 p. |
artikel |
75 |
PATIENT-REPORTED XEROSTOMIA AT DAY OR AT NIGHT: IMPORTANCE OF THE SUBMANDIBULAR GLAND FUNCTION AFTER RT
|
Terhaard, C. |
|
2011 |
98 |
S1 |
p. S21-S22 2 p. |
artikel |
76 |
PATTERN OF FAILURE AND HiSTOPATHOLOGICAL FEATURES IN PATIENTS WITH POSITIVE POSTRADIATION PLANNED NECK DISSECTION
|
Huang, S.H. |
|
2011 |
98 |
S1 |
p. S31- 1 p. |
artikel |
77 |
PHOTODYNAMIC ELECTION THERAPY WITH TEMOPORFIRIN (PDT) IN SURFACE NEOPLASTIC AND PRENEOPLASTIC OBLIGED MOUTH LESIONS. PRELIMINARY ASSESSMENT OF THE RESULTS
|
Parmigiani, F. |
|
2011 |
98 |
S1 |
p. S40- 1 p. |
artikel |
78 |
P16 IMMUNOHISTOCHEMISTRY AND HPV-PCR FOR RESPONSE PREDICTION AFTER RADIOTHERAPY IN HNSCC
|
Van Limbergen, E. |
|
2011 |
98 |
S1 |
p. S10- 1 p. |
artikel |
79 |
PLANNED NECK DISSECTION AFTER CHEMIORADIOTHERAPY IN LOCALLY ADVANCED OROPHARYNGEAL CANCER
|
Manciocco, V. |
|
2011 |
98 |
S1 |
p. S22- 1 p. |
artikel |
80 |
PREDICTIVE MODELS FOR DYSPHAGIA AFTER (CHEMO) RADIATION IN HEAD AND NECK CANCER: A MULTI-CENTER PROSPECTIVE COHORT STUDY
|
Christianen, M. |
|
2011 |
98 |
S1 |
p. S13-S14 2 p. |
artikel |
81 |
PREDICTIVE VALUE OF PIMONIDAZOLE FOR ARCON THERAPY IN ADVANCED HEAD AND NECK CANCER
|
Rademakers, S. |
|
2011 |
98 |
S1 |
p. S40-S41 2 p. |
artikel |
82 |
PRELIMINARY EXPERIENCE WITH HELICAL TOMOTHERAPY USING SIMULTANEOUS INTEGRATED BOOST (SIB) IN NASOPHARYNX CANCER
|
Bacigalupo, A. |
|
2011 |
98 |
S1 |
p. S31-S32 2 p. |
artikel |
83 |
PRELIMINARY RESULTS OF INDUCTION CHEMOTHERAPY WITH TPF IN LOCALLY ADVANCED HEAD AND NECK CANCER IN ASSOCIATION WITH HPV STATUS
|
Xesfyngi, D. |
|
2011 |
98 |
S1 |
p. S41- 1 p. |
artikel |
84 |
PRIMARY MALIGNANCIES OF NOSE AND PARANASAL SINUSES. A SURGICAL SERIES OF 91 CASES
|
Almadori, G. |
|
2011 |
98 |
S1 |
p. S32- 1 p. |
artikel |
85 |
PROCEDURE OF HIGH PRECISION FUSION OF CT-MRI IMAGES FOR HEAD-NECK CANCER WITH NEW ANTENNA FRAME
|
Velazquez Miranda, S. |
|
2011 |
98 |
S1 |
p. S41- 1 p. |
artikel |
86 |
PROGNOSTIC VALUE OF HYPOXIAMARKERS HIF-1A, CA IX AND OPN IN T1-T2 LARYNGEAL CARCINOMAS TREATED WITH PRIMARILY RT
|
Wächters, J.E. |
|
2011 |
98 |
S1 |
p. S41-S42 2 p. |
artikel |
87 |
PROGNOSTIC VALUES OF TUMOR BLOOD FLOW, [18F]EF5 AND [18F]FDG PET/CT IMAGING IN PATIENTS WITH HEAD AND NECK CANCER
|
Komar, G. |
|
2011 |
98 |
S1 |
p. S8- 1 p. |
artikel |
88 |
QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEAD AND NECK CANCER PATIENTS: DOES QUALITY OF LIFE PREDICT LONG-TERM SURVIVAL?
|
Tarsitano, A. |
|
2011 |
98 |
S1 |
p. S12-S13 2 p. |
artikel |
89 |
RADIOTHERAPY AND COMBINED MODALITIES FOR HEAD AND NECK CANCERS: TWO YEAR SURVIVAL AND TOXICITY OUTCOMES FROM A REGIONAL CANCER CENTRE IN UK
|
Dandamudi, R. |
|
2011 |
98 |
S1 |
p. S22- 1 p. |
artikel |
90 |
RANDOMIZED TRIAL OF CONCURRENT CHEMORADIATION WITH CARBOPLATIN AND 5 FLUOROURACIL VERSUS CONCOMITANT BOOST IRRADIATION IN LOCALLY ADVANCED HEAD AND NECK CANCER
|
Chitapanarux, I. |
|
2011 |
98 |
S1 |
p. S32- 1 p. |
artikel |
91 |
RECENT IMAGING DEVELOPMENTS
|
Hermans, R. |
|
2011 |
98 |
S1 |
p. S11- 1 p. |
artikel |
92 |
RE-IRRADIATION IN HEAD AND NECK CANCER
|
Lartigau, E. |
|
2011 |
98 |
S1 |
p. S16- 1 p. |
artikel |
93 |
RESISTANCE TRAINING AND DIETARY SUPPLEMENTS AS INTERVENTION FOR REGAINING MUSCLE MASS FOLLOWING RADIOTHERAPY IN HEAD AND NECK CANCER PATIENTS
|
Lanbro, S. |
|
2011 |
98 |
S1 |
p. S42- 1 p. |
artikel |
94 |
RESULTS OF CONCURRENT CHEMORADIATION IN HEAD AND NECK CANCER WITH HYPOFRACTIONATED PROTOCOL OF 60GY/25#/5 WEEKS WITH WEEKLY CISPLATIN
|
Kumar, M. |
|
2011 |
98 |
S1 |
p. S32-S33 2 p. |
artikel |
95 |
RISK FACTORS AND LOCATION OF OCCULT LYMPH NODES METASTASIS IN CT1-T2N0M0 SQUAMOUS CELL CARCINOMA OF THE TONGUE AND THE FLOOR OF THE MOUTH
|
Magremanne, M. |
|
2011 |
98 |
S1 |
p. S33- 1 p. |
artikel |
96 |
ROBOTIC HEAD AND NECK SURGERY AND ITS ROLE WITHIN THE MULTIDISCIPLINARY PARADIGM
|
Holsinger, C. |
|
2011 |
98 |
S1 |
p. S11-S12 2 p. |
artikel |
97 |
SENTINEL NODE BIOPSY IN T1-T2 ORAL AND OROPHARYNGEAL CANCER REDUCES THE RISK OF OCCULT LYMPH NODE METASTASES
|
Flach, G. |
|
2011 |
98 |
S1 |
p. S42- 1 p. |
artikel |
98 |
SETUP DIFFERENCES WHEN USING DIFFERENT IGRT ALIGNMENT PRACTICES FOR HEAD AND NECK IMRT PATIENTS
|
Graff, P. |
|
2011 |
98 |
S1 |
p. S33- 1 p. |
artikel |
99 |
SIMULTANEOUS INTEGRATED BOOST WITH VOLUMETRIC INTENSITY MODULATED RADIOTHERAPY (RAPID ARC) IN THE RADICAL TREATMENT OF 47 ADVANCED HEAD AND NECK CANCER PATIENTS: A PRELIMINARY REPORT
|
Alongi, F. |
|
2011 |
98 |
S1 |
p. S33-S34 2 p. |
artikel |
100 |
SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN DENMARK 2004–2008 – A NATIONWIDE STUDY FROM DAHANCA
|
Grau, C. |
|
2011 |
98 |
S1 |
p. S12- 1 p. |
artikel |
101 |
STATE OF THE ART IN THE TREATMENT OF LARYNX TUMOURS
|
Guigay, J. |
|
2011 |
98 |
S1 |
p. S15- 1 p. |
artikel |
102 |
STATE OF THE ART IN THE TREATMENT OF ORAL CAVITY TUMOURS
|
Mehanna, H. |
|
2011 |
98 |
S1 |
p. S15- 1 p. |
artikel |
103 |
STATE OF THE ART IN THE TREATMENT OF OROPHARYNX TUMOURS
|
Grau, C. |
|
2011 |
98 |
S1 |
p. S15- 1 p. |
artikel |
104 |
STUDY OF MICRORNAS' EXPRESSION PROFILE IN HEAD AND NECK CANCER
|
Manciocco, V. |
|
2011 |
98 |
S1 |
p. S25- 1 p. |
artikel |
105 |
SURGICAL SALVAGE FOR HEAD AND NECK TUMORS AFTER CHEMORADIATION FAILURE
|
Leemans, C.R. |
|
2011 |
98 |
S1 |
p. S17- 1 p. |
artikel |
106 |
SURVIVAL AND FUNCTIONAL OUTCOMES FOR A POPULATION BASED COHORT OF PATIENTS WITH SYAGES III AND IV SQUAMOUS CARCINOMA OF THE OROPHYARYNX TREATED RADICALLY WITH CHEMO-RADIATION OR RADIATION ALONE
|
Myers, C. |
|
2011 |
98 |
S1 |
p. S22-S23 2 p. |
artikel |
107 |
TARGETED THERAPY IN REFRACTORY THYROID CANCER
|
Schlumberger, M. |
|
2011 |
98 |
S1 |
p. S7- 1 p. |
artikel |
108 |
TAXANE-CISPLATIN-5FU AS INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE MACH-NC GROUP
|
Blanchard, P. |
|
2011 |
98 |
S1 |
p. S6- 1 p. |
artikel |
109 |
THE BEHAVIOUR OF ELDERLY PATIENTS TREATED WITH CHEMORADIATION. A SINGLE INSTITUTION EXPERIENCE
|
Merlano, M. |
|
2011 |
98 |
S1 |
p. S13- 1 p. |
artikel |
110 |
THE ESTIMATION OF LATE RADIATION REACTION OF SALIVARY GLANDS IN PATIENTS WITH SQUAMOUS CELL CANCER IRRADIATED IN HEAD&NECK REGION – THE PROSPECTIVE STUDY
|
Golen, M. |
|
2011 |
98 |
S1 |
p. S23- 1 p. |
artikel |
111 |
THE INCIDENCE OF HYOPTHYROIDISM IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK TREATED WITH RADICAL RADIOTHERAPY AND CITUXIMAB
|
Borg, M. |
|
2011 |
98 |
S1 |
p. S23- 1 p. |
artikel |
112 |
THERAPEUTIC RESULTS OF NASOPHARYNGEAL CARCINOMA: A COMPARAISON BETWEEN CHILDREN AND ADULTS. A TUNISIAN EXPERIENCE
|
Daoued, J. |
|
2011 |
98 |
S1 |
p. S42-S43 2 p. |
artikel |
113 |
THE RESULTS AND TOXICITY OF ORGAN PRESERVATION TREATMENT IN PATENTS WITH LOCOREGIONALLY ADVANCED LARYNGEAL AND HYPOPHARYNGEAL CANCER
|
Kiprian, D. |
|
2011 |
98 |
S1 |
p. S34- 1 p. |
artikel |
114 |
THE ROLE OF 18-FDG PET-CT IN LOCALLY ADVANCED HEAD AND NECK CANCER PATIENTS: EARLY AND LATE RESPONSE TO RADIOCHEMOTHERAPY
|
Micciche, F. |
|
2011 |
98 |
S1 |
p. S45-S46 2 p. |
artikel |
115 |
THE VIEW POINT OF THE ADVOCACY GROUP ON PATIENT MANAGEMENT
|
Brook, M. |
|
2011 |
98 |
S1 |
p. S16- 1 p. |
artikel |
116 |
TOMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER-DOES IT REDUCE XEROSTOMIA?
|
Goy, Y. |
|
2011 |
98 |
S1 |
p. S34- 1 p. |
artikel |
117 |
TOXICITY AND CLINICAL OUTCOME OF TWO CONCURRENT CHEMORADIATION SCHEDULE (PLATINUM BASED WITH IMRT-SIB) FOR LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
|
Martucci, F. |
|
2011 |
98 |
S1 |
p. S34-S35 2 p. |
artikel |
118 |
TREATMENT AND OUTCOME OF ADVANCED EXTERNAL EAR SCC
|
Cristalli, G. |
|
2011 |
98 |
S1 |
p. S43- 1 p. |
artikel |
119 |
TREATMENT APPROACHES OF NON SQUAMOUS CELL SINONASAL MALIGNANCIES
|
Licitra, L. |
|
2011 |
98 |
S1 |
p. S18- 1 p. |
artikel |
120 |
UPA, UPAR AND MASPIN EXPRESSION AS A BIOMARKER IN INVASIVE ORAL SQUAMOUS CELL CARCINOMA
|
Yoshizawa, K. |
|
2011 |
98 |
S1 |
p. S27- 1 p. |
artikel |
121 |
VALUE BASED CANCER CARE
|
Forastière, A. |
|
2011 |
98 |
S1 |
p. S15- 1 p. |
artikel |
122 |
WHAT IS NEW IN MEDICAL TREATMENT (NEW AND FUTURE DRUGS AND CONCEPT)?
|
Boshoff, C. |
|
2011 |
98 |
S1 |
p. S17- 1 p. |
artikel |